A Study to Evaluate the Safety and Efficacy of 3% LTX-109 for Nasal Decolonisation of Staphylococcus

Clinical trial NCT04767321 · COMPLETED

Trial details

NCT number: NCT04767321
Sponsor: Pharma Holdings AS
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Nasal Decolonization of Staphylococcus Aureus

Start date: 2021-02-22
Primary completion: 2021-03-23
Enrollment: 15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.